📰 Evaluate Safety News
Page 3 - Evaluate Safety News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Evaluate Safety. Real-time updates on events, politics, business and more.
November 17, 2023
- TAKHZYRO® is the First Routine Prevention Treatment of HAE Approved in the EU for Patients Under the Age...
November 14, 2023
DelveInsights Brain Hemorrhage Pipeline Insight 2023 report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in the Brain Hemorrhage pipeline landscape. It covers the Brain...
November 2, 2023
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...
September 22, 2023
ZURICH, Sept. 22, 2023 /PRNewswire/ -- Takeda (TSE:4502) (NYSE:TAK) today announced the European Medicines...
July 31, 2023
Pharmacists play a key role in the management of modern monoclonal antibody treatments for Alzheimer disease.
May 17, 2023
Heart Rhythm 2023, the society's 44th annual meeting, takes place May 19-21, in New Orleans
April 24, 2023
/PRNewswire/ -- Justin Zenanko, CEO of SynerFuse™, is proud to announce that Michael Park, M.D., associate professor of neurosurgery at the University of...
March 27, 2023
You should read the following discussion and analysis of our financial condition and results of operations together with our audited consolidated financial statements and notes thereto for the... | March 27, 2023
February 13, 2023
Trial to Evaluate Safety, Tolerability and Clinical Activity in Solid Tumors Expressing 5T4LUND, SWEDEN and SEATTLE, WA / ACCESSWIRE / February 13, 2023 / Alligator Bioscience AB ("Alligator") (Nasdaq
January 9, 2023
/PRNewswire/ -- Justin Zenanko, CEO of SynerFuse, Inc., a Minnesota-based medical device company, is pleased to announce that for the first time in the world,...